Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunoglobulin prophylaxis for viral hepatitis.

C S Feng

    The Journal of Family Practice
    |April 1, 1982
    PubMed
    Summary

    Immune serum globulin (ISG) is a cost-effective option for hepatitis A and B prophylaxis. Accurate serological testing is crucial for rational immunoprophylaxis decisions in viral hepatitis management.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Applying the Fisher score to identify Alzheimer's disease-related genes.

    Genetics and molecular research : GMR·2016
    Same author

    Holographic design of a two-dimensional photonic crystal of square lattice with pincushion columns and large complete band gaps.

    Optics express·2009
    Same author

    Jehovah's Witnesses and surgery.

    Hong Kong medical journal = Xianggang yi xue za zhi·2005
    Same author

    Paper version of the Hong Kong Medical Journal should stay.

    Hong Kong medical journal = Xianggang yi xue za zhi·2000
    Same author

    T-acute lymphoblastic leukemia with cytoplasmic granules.

    American journal of hematology·1997
    Same author

    Haemostatic changes during surgery for primary brain tumours.

    Journal of neurology, neurosurgery, and psychiatry·1997

    Area of Science:

    • Hepatology and Immunology
    • Infectious Diseases
    • Public Health

    Background:

    • Viral hepatitis remains a significant global health concern despite advancements.
    • Immunoglobulin prophylaxis is established for hepatitis A and B, but cost and efficacy vary.
    • Hepatitis non-A, non-B lacks specific immunoglobulin, with undetermined ISG efficacy.

    Purpose of the Study:

    • To evaluate the indications and cost-effectiveness of immunoglobulin prophylaxis for viral hepatitis.
    • To emphasize the importance of serological markers in guiding immunoprophylaxis strategies.
    • To discuss the current limitations and future directions in viral hepatitis prevention.

    Main Methods:

    • Review of current literature on immunoglobulin prophylaxis for viral hepatitis A and B.
    • Analysis of the cost-effectiveness of Hepatitis B immune globulin (HBIG) versus Immune Serum Globulin (ISG).
    • Discussion of the role of laboratory serological testing in identifying hepatitis types and patient immunity status.

    Main Results:

    • Hepatitis B immune globulin (HBIG) is specific but costly; Immune Serum Globulin (ISG) is effective and cost-effective for hepatitis A and B.
    • Serological testing is essential to confirm hepatitis type and identify individuals who do not require passive immunization.
    • The efficacy of ISG for hepatitis non-A, non-B remains undetermined.

    Conclusions:

    • ISG should be considered the preferred agent for hepatitis A and B prophylaxis due to its cost-effectiveness.
    • Rational immunoprophylaxis requires accurate diagnosis through serological testing to avoid unnecessary treatment.
    • Future control of viral hepatitis hinges on developing vaccines for all types and reliable tests for hepatitis non-A, non-B.

    Related Experiment Videos